References
- World Health Organization. 1996. Cancer pain relief: with a guide to opioid availability. 2nd ed. WHO Library Cataloguing in Publication Data.
- Sindt J, Brogan S. Interventional treatments of cancer pain anesthesiology clin. Anesthesiol Clin. 2016;34:317–339.
- Swarm R, Abernethy A, Anghelescu D. Adult cancer pain. J Natl Compr Canc Netw. 2013;11(8):992–1022.
- Zhong W, Yu Z, Zeng JX, et al. Celiac plexus block for treatment of pain associated with pancreatic cancer: a meta-analysis. Pain Pract. 2014;14(1):43–51.
- Amr YM, Makharita MY. Neurolytic sympathectomy in the management of cancer pain-time effect: a prospective, randomized multicenter study. J Pain Symptom Manage. 2014;48(5):944–956 e942.
- Wong GY, Schroeder DR, Carns PE, et al. Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial. JAMA. 2004;291(9):1092–1099.
- Mercadante S, Klepstad P, Kurita G, et al. Sympathetic blocks for visceral cancer pain management: a systematic review and EAPC recommendation. Crit Rev Oncol Hematol. 2015;96(3):577–583.
- Rocha A, Hernández-Porras RR, Plancarte R, et al. Effectiveness of superior hypogastric plexus neurolysis for pelvic cancer pain. Pain Physician. 2020;23(2):203-208.
- Plancarte R, Guajardo J, Meneses A, et al. Clinical benefits of femoroplasty: a novel technique. Pain Physician 2014; 17:227-234.
- Cazzato R, Palussière J, Buy X, et al. Percutaneous long bone cementoplasty for palliation of malignant lesions of the limbs: a systematic review. Cardiovasc Intervent Radiol. 2015;38(6):1563–1572.
- Kurita GP, Sjogren P, Klepstad P. Interventional techniques to management of cancer-related pain: clinical and critical aspects. Cancers (Basel). 2019;443(11):1–12.
- Fallon M, Giusti R, Aielli F. Management of cancer pain in adult patients: ESMO clinical practice guidelines. Ann Oncol. 2018;4(29):iv166–iv191.
- Vayne-Bossert P, Afsharimani B, Good P, et al. Interventional options for the management of refractory cancer pain—what is the evidence? Support Care Cancer. 2016;24(3):1429-1438.
- Plancarte SR, Guajardo J, Guillén R. Neurolytic techniques for cancer pain management, Oscar de Leon Casasola. Cancer pain pharmacological, interventional and palliative care approaches. Philadelphia, USA: Saunders Elsevier; 2006. p. 501–507.
- Viswanathan A, Vedantam A, Hess K, et al. Minimally invasive cordotomy for refractory cancer pain: a randomized controlled trial. Oncologist. 2019;24(7):e590–e596.
- Maher D, Walia D, Heller N. Suppression of human natural killer cells by different classes of opioids. Anesth Analg. 2019;128(5):1013–1021.
- Franchi S, Moschetti G, Amodeo G, et al. Do all opioid drugs share the same immunomodulatory properties? A review from animal and human studies. Front Immunol. 2019;1(10):11.